The CEO of Novo Nordisk took questions for more than two hours during a Senate Health Committee hearing focused on addressing ...

For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...

The Risky Research Review Act, now before the Senate, “could finally require independent oversight” around risks like gain-of ...

U.S. senators questioned Novo Nordisk CEO Lars Fruergaard Jørgensen about the high costs of the company's GLP-1 drugs, which include popular weight-loss drugs Wegovy and Ozempic. It comes after North ...

Every four years, without fail, I’m assured that the Jewish vote is finally up for grabs. Every four years, the prediction turns out to be completely wrong. One strongly suspects 2024 will be no ...

"All we are saying [to Novo Nordisk] is, Treat the American people the same way that you treat people all over the world.

Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today led the committee in a hearing to ...

Novo Nordisk CEO Lars Fruergaard Jørgensen, however, said that lowering the prices could result in unintended consequences ...

Senators grilled Novo Nordisk CEO Lars Jorgensen at a hearing on Tuesday about the cost of diabetes drug Ozempic and weight ...

Vice President Kamala Harris said this week she supports an "elimination" of the Senate's filibuster rule in order to push ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...